טוען...
Effect of rapamycin on aging and age-related diseases—past and future
In 2009, rapamycin was reported to increase the lifespan of mice when implemented later in life. This observation resulted in a sea-change in how researchers viewed aging. This was the first evidence that a pharmacological agent could have an impact on aging when administered later in life, i.e., an...
שמור ב:
| הוצא לאור ב: | GeroScience |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8190242/ https://ncbi.nlm.nih.gov/pubmed/33037985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-020-00274-1 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|